"Pathway","pVal","pValFDR","pValBonferroni","Genes","HitGenes","HitGeneNames"
"Spliceosome",0,0,0,132,48,"SF3B4, SF3A1, SLU7, PRPF8, USP39, TCERG1, SF3A3, SF3B2, RBMXL3, ZMAT2, DHX15, SNW1, ACIN1, U2SURP, SF3B3, SF3B1, PRPF6, PRPF40B, SYF2, TRA2A, HNRNPC, HNRNPU, NCBP1, CDC40, LSM7, PLRG1, XAB2, THOC2, ISY1, LSM2, SRSF2, SRSF3, TRA2B, SNRPA, SNRPA1, SNRPB, SNRPC, SNRPD3, SNRPE, SNRPG, SF3A2, SF3B5, PRPF38A, RBM17, PRPF18, AQR, EIF4A3, RBM8A"
"RNA polymerase",0,0,0,31,13,"POLR3G, POLR2J2, POLR2B, POLR2C, POLR2D, POLR2E, POLR2F, POLR2G, POLR2I, POLR2J, POLR2K, POLR2L, POLR3E"
"Thyroid hormone signaling pathway",0,0,0.001,116,23,"DIO2, EP300, MED4, HDAC2, HRAS, MYH6, ATP1B3, PFKFB2, PIK3CA, PIK3R2, PLCD1, MED1, PRKACB, MAP2K2, RXRB, ACTG1, NCOA1, PLCZ1, MED30, MED14, MED17, MED27, TBC1D4"
"Non-alcoholic fatty liver disease (NAFLD)",0,0,0.001,148,27,"NR1H3, NDUFA11, COX4I1, UQCR10, FAS, IKBKB, IL1A, IL6R, NDUFS7, LEPR, UQCRHL, NDUFA6, NDUFA10, NDUFS6, ADIPOR1, PIK3CA, PIK3R2, CYCS, NDUFB11, RAC1, RELA, UQCRB, UQCRC1, UQCRC2, UQCRFS1, XBP1, COX4I2"
"Cytokine-cytokine receptor interaction",0,0.004,0.021,268,36,"TNFSF13B, IL17RE, CX3CR1, TNFRSF13B, IL17RA, GH2, AMHR2, GHR, CCR10, IFNL1, IFNA4, IFNA7, IFNA16, IFNB1, IFNW1, FAS, IL1A, IL2, IL6R, IL7R, LEPR, LTBR, OSM, TNFRSF12A, PRL, CXCL16, IL22RA1, CXCL12, TGFB3, TNFRSF4, CXCR4, TNFSF11, TNFRSF10A, IL18RAP, ACVR1B, OSMR"
"Regulation of actin cytoskeleton",0,0.005,0.03,211,30,"GNA13, NCKAP1, CHRM3, DIAPH1, DOCK1, SPATA13, FGF9, CYFIP1, ARHGEF12, CYFIP2, GNA12, HRAS, ITGA2B, ITGAL, ITGB5, RHOA, MYH10, PAK3, PFN2, PIK3CA, PIK3R2, PPP1R12C, BRK1, MAP2K2, RAC1, RRAS, ACTG1, PIP5K1B, ACTN1, IQGAP1"
"Axon guidance",0,0.005,0.038,174,26,"SEMA3A, EFNA1, ARHGEF12, HRAS, RHOA, ABLIM1, NTN3, PAK3, PARD6A, PIK3CA, PIK3R2, SEMA5B, PLXNA3, DPYSL5, SEMA4G, RAC1, ROBO1, RRAS, CXCL12, SLIT1, CXCR4, CAMK2A, NCK2, PLXNA4, NTN1, SEMA3E"
"Proteasome",0,0.006,0.047,45,11,"PSMD14, PSMA3, PSMA7, PSMB6, PSMB7, PSMC3, PSMC4, PSMD2, PSMD4, PSMD7, PSMF1"
"Endocrine resistance",0,0.007,0.062,95,17,"CARM1, DLL3, JAG1, E2F2, ERBB2, DLL1, GPER1, HRAS, MMP9, PIK3CA, PIK3R2, MED1, PRKACB, MAP2K2, MAPK12, BIK, SP1"
"Cytosolic DNA-sensing pathway",0,0.007,0.066,62,13,"POLR3G, IFNA4, IFNA7, IFNA16, IFNB1, IKBKB, POLR2E, POLR2F, POLR2K, POLR2L, POLR3E, RELA, IL33"
"T cell receptor signaling pathway",0.001,0.013,0.147,102,17,"LAT, HRAS, IKBKB, IL2, RHOA, LCK, PAK3, PIK3CA, PIK3R2, MAP2K2, RELA, MAPK12, NCK2, CARD11, CBLB, BCL10, CD4"
"Cardiac muscle contraction",0.001,0.017,0.208,78,14,"COX4I1, UQCR10, UQCRHL, MYH6, ATP1B3, CACNA2D3, ACTC1, TPM3, UQCRB, UQCRC1, UQCRC2, UQCRFS1, COX4I2, CACNA2D4"
"Jak-STAT signaling pathway",0.001,0.02,0.267,156,22,"CISH, EP300, GH2, GHR, IFNL1, HRAS, IFNA4, IFNA7, IFNA16, IFNB1, IFNW1, IL2, IL6R, IL7R, LEPR, OSM, PIK3CA, PIM1, PIK3R2, PRL, IL22RA1, OSMR"
"Ubiquitin mediated proteolysis",0.001,0.02,0.289,137,20,"UBE2QL1, PPIL2, FBXO2, ANAPC2, UBR5, UBE2D4, UBE2R2, UBE2W, UBE2Q1, SMURF1, SMURF2, UBE2B, UBE2D2, UBE2E1, CBLB, CDC23, CDC16, UBE3B, UBE2Q2, CDC27"
"Pyrimidine metabolism",0.001,0.02,0.297,99,16,"POLR3G, POLR2J2, POLR2B, POLR2C, POLR2D, POLR2E, POLR2F, POLR2G, POLR2I, POLR2J, POLR2K, POLR2L, POLR3E, POLE4, CAD, ENTPD1"
"Notch signaling pathway",0.001,0.022,0.353,48,10,"DLL3, DTX3L, JAG1, DVL1, EP300, SNW1, DTX4, DLL1, HDAC2, HES1"
"Tight junction",0.001,0.022,0.367,170,23,"TUBA1B, ERBB2, TJP3, RHOA, MYH10, PARD6A, AMOTL2, RAPGEF6, PPP2R1A, PRKACB, RAC1, RAP1A, ACTG1, CLDN5, TUBA4A, VASP, TUBAL3, CGNL1, ACTN1, MPDZ, CD1C, CD1D, TJAP1"
"Leukocyte transendothelial migration",0.002,0.024,0.431,112,17,"CYBB, ITGAL, RHOA, MMP9, NCF2, NCF4, PIK3CA, PIK3R2, RAC1, RAP1A, MAPK12, CXCL12, ACTG1, CLDN5, VASP, CXCR4, ACTN1"
"Natural killer cell mediated cytotoxicity",0.002,0.031,0.586,125,18,"FCER1G, FCGR3B, LAT, HRAS, IFNA4, IFNA7, IFNA16, IFNB1, FAS, ITGAL, KIR3DL1, KLRC2, LCK, PIK3CA, PIK3R2, MAP2K2, RAC1, TNFRSF10A"
"AGE-RAGE signaling pathway in diabetic complications",0.003,0.04,0.804,99,15,"COL4A2, CYBB, DIAPH1, HRAS, IL1A, SERPINE1, PIK3CA, PIM1, PIK3R2, PLCD1, PRKCD, RAC1, RELA, MAPK12, TGFB3"
"Oxidative phosphorylation",0.004,0.051,1,132,18,"NDUFA11, COX4I1, UQCR10, NDUFS7, UQCRHL, NDUFA6, NDUFA10, NDUFS6, ATP5B, ATP6V0C, NDUFB11, PPA1, UQCRB, UQCRC1, UQCRC2, UQCRFS1, COX4I2, ATP6V1F"
"NF-kappa B signaling pathway",0.005,0.053,1,93,14,"TAB1, TNFSF13B, TIRAP, LAT, IKBKB, LCK, LTBR, PLAU, RELA, CXCL12, TNFAIP3, CARD11, TNFSF11, BCL10"
"ErbB signaling pathway",0.005,0.059,1,85,13,"NRG4, ERBB2, ERBB3, EREG, HRAS, PAK3, PIK3CA, PIK3R2, MAP2K2, TGFA, CAMK2A, NCK2, CBLB"
"Ras signaling pathway",0.007,0.071,1,225,26,"EFNA1, ETS1, FGF9, RGL1, PLA2G4F, RASGRP3, PLA2G2D, LAT, GNB3, ANGPT1, GRIN2B, HRAS, IKBKB, RHOA, PAK3, PIK3CA, PIK3R2, PRKACB, MAP2K2, RAC1, RAP1A, GNB4, RELA, RRAS, GNG8, RIN1"
"B cell receptor signaling pathway",0.008,0.083,1,70,11,"RASGRP3, HRAS, IKBKB, PIK3CA, PIK3R2, MAP2K2, RAC1, RELA, CARD11, BCL10, CD22"
"Rap1 signaling pathway",0.01,0.1,1,210,24,"EFNA1, FGF9, RASGRP3, LAT, ANGPT1, GRIN2B, HRAS, ITGA2B, ITGAL, RHOA, PARD6A, RAPGEF6, PFN2, PIK3CA, PIK3R2, MAP2K2, RAC1, RAP1A, RRAS, MAPK12, ARAP3, ACTG1, VASP, TLN2"
"PI3K-Akt signaling pathway",0.012,0.103,1,340,35,"YWHAQ, COL4A2, EFNA1, CRTC2, FGF9, G6PC, GH2, GHR, GNB3, ANGPT1, HRAS, IFNA4, IFNA7, IFNA16, IFNB1, IKBKB, IL2, IL6R, IL7R, ITGA2B, ITGB5, OSM, PIK3CA, PIK3R2, PPP2R1A, PKN2, MAP2K2, PRL, RAC1, GNB4, RELA, TNXB, OSMR, GNG8, CREB5"
"TGF-beta signaling pathway",0.012,0.103,1,83,12,"EP300, AMHR2, RHOA, NODAL, PITX2, PPP2R1A, SMURF1, SMURF2, SP1, TGFB3, LEFTY2, ACVR1B"
"Fc epsilon RI signaling pathway",0.015,0.128,1,66,10,"FCER1G, ALOX5AP, PLA2G4F, LAT, HRAS, PIK3CA, PIK3R2, MAP2K2, RAC1, MAPK12"
"Focal adhesion",0.019,0.156,1,198,22,"COL4A2, DIAPH1, DOCK1, ERBB2, PARVB, HRAS, ITGA2B, ITGB5, RHOA, PAK3, PIK3CA, PIK3R2, PPP1R12C, RAC1, RAP1A, ACTG1, TNXB, VASP, ZYX, TLN2, CAV2, ACTN1"
"Phospholipase D signaling pathway",0.021,0.156,1,144,17,"AGPAT1, GNA13, DNM2, FCER1G, PLA2G4F, GNA12, GRM4, GRM6, HRAS, RHOA, PIK3CA, PIK3R2, MAP2K2, RRAS, PIP5K1B, DGKZ, DGKD"
"Platelet activation",0.021,0.156,1,122,15,"GNA13, FCER1G, ARHGEF12, PLA2G4F, ITGA2B, RHOA, PIK3CA, PIK3R2, PRKACB, PTGIR, RAP1A, MAPK12, ACTG1, VASP, TLN2"
"mRNA surveillance pathway",0.021,0.156,1,90,12,"RNPS1, CSTF2, ETF1, ACIN1, SSU72, NCBP1, PPP2R1A, UPF3B, PABPN1, EIF4A3, SMG7, RBM8A"
"Prolactin signaling pathway",0.022,0.156,1,70,10,"CISH, CSN2, HRAS, PIK3CA, PIK3R2, MAP2K2, PRL, RELA, MAPK12, TNFSF11"
"RIG-I-like receptor signaling pathway",0.022,0.156,1,70,10,"DDX3X, IFNA4, IFNA7, IFNA16, IFNB1, IFNW1, IKBKB, RELA, MAPK12, NLRX1"
"Toll-like receptor signaling pathway",0.024,0.164,1,102,13,"TAB1, TIRAP, IFNA4, IFNA7, IFNA16, IFNB1, IKBKB, PIK3CA, PIK3R2, MAP2K2, RAC1, RELA, MAPK12"
"Apoptosis",0.029,0.197,1,138,16,"TUBA1B, HTRA2, HRAS, FAS, IKBKB, LMNB1, PIK3CA, PIK3R2, CYCS, MAP2K2, PTPN13, RELA, ACTG1, TUBA4A, TUBAL3, TNFRSF10A"
"Sphingolipid signaling pathway",0.034,0.218,1,118,14,"GNA13, ACER1, FCER1G, GNA12, HRAS, RHOA, PIK3CA, PIK3R2, PPP2R1A, MAP2K2, ASAH2, RAC1, RELA, MAPK12"
"Intestinal immune network for IgA production",0.034,0.218,1,45,7,"TNFSF13B, TNFRSF13B, CCR10, IL2, LTBR, CXCL12, CXCR4"
"TNF signaling pathway",0.036,0.223,1,108,13,"TAB1, JAG1, FAS, IKBKB, MMP3, MMP9, PIK3CA, PIK3R2, RELA, MAPK12, TNFAIP3, RPS6KA4, CREB5"
"AMPK signaling pathway",0.038,0.225,1,120,14,"EEF2, CRTC2, FBP1, G6PC, ACACB, LEPR, ADIPOR1, CAB39, PFKFB2, PIK3CA, PIK3R2, PPP2R1A, CCNA1, CREB5"
"Vascular smooth muscle contraction",0.038,0.225,1,120,14,"CALCRL, RAMP1, GNA13, ARHGEF12, PLA2G4F, PLA2G2D, GNA12, RHOA, PPP1R12C, PRKACB, PRKCD, PRKCH, MAP2K2, PTGIR"
"RNA transport",0.039,0.226,1,166,18,"RNPS1, NUP35, ACIN1, CYFIP1, NUP62, CYFIP2, KPNB1, NCBP1, NUP98, POP5, NUP107, THOC2, RANBP2, UPF3B, NUP93, EIF4A3, RBM8A, NUP153"
"HIF-1 signaling pathway",0.041,0.231,1,99,12,"CYBB, EP300, ERBB2, ANGPT1, IL6R, LTBR, SERPINE1, PIK3CA, PIK3R2, MAP2K2, RELA, CAMK2A"
